CDNA
Overvalued by 109.2% based on the discounted cash flow analysis.
Market cap | $808.52 Million |
---|---|
Enterprise Value | $798.16 Million |
Dividend Yield | $- (-) |
Earnings per Share | $1 |
Beta | 2.37 |
Outstanding Shares | 54,304,754 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 15.96 |
---|---|
PEG | 3.1 |
Price to Sales | 2.53 |
Price to Book Ratio | 2.53 |
Enterprise Value to Revenue | 2.34 |
Enterprise Value to EBIT | 18.89 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0.07 |
Debt to Equity | 0.18 |
No data
No data